26 results
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... other factors (e.g ... ., concomitant medications ... Treatment #management #opportunistic ... #pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... community-acquired pneumonia, MV ... InfectiousDiseases #Infections ... #Pharmacology # ... Management #Treatment #Indications
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
loss (>5 lb; 2.5 kg ... Presentations: • Opportunistic ... in which case opportunistic ... Cytomegalovirus (CMV ... HIV-1 p24 core Ag
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... amphotericin B, 3 to 5 mg/kg ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... canagliflozin ↓ CV ... hypovolemia) • GU infections ... (e.g. ... SGLT2 #Inhibitors #Pharmacology
Drug Induced Liver Injury (DILI) - Stepwise Diagnosis Algorithm
DILI suspicion
Features toxic aetiology: Skin involvement, Kidney injury,
of information (e.g ... duration), Several medications ... Hepatocellular: Viral infections ... HCV, HEV, EBV, CMV ... vascular disorder (e.g
Causes of Chronic Diarrhea - Differential Diagnosis
Osmotic
 • Food/Drink: Lactose intolerance, Artificial sweeteners (e.g. sorbitol, high
Artificial sweeteners (e.g ... corn syrup) • Medications ... Inflammatory - Infectious ... AIDS enteritis, CMV ... Inflammatory - Non-infectious
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... /day or weekly injection ... variety of adverse CV ... side effects (e.g ... Receptor #Agonists #Pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab 11mg/kg ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications